EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study

Véronique Turcotte, Laurence Guillaumie, Martine Lemay, Anne Dionne, Julie Lemieux, Angéline Labbé, Carolyn Gotay, Line Guénette iD, Sophie Lauzier

Current Oncology · 2025

DOI: 10.3390/curroncol32010045 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Current Oncology, 2025. Verfasst von Véronique Turcotte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Population Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Health Personnel, Antineoplastic Agents, Hormonal, Medication Adherence. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Fondation du CHU de Québec-Université Laval, Unité Soutien SSA du Québec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year program designed to enhance the AET experience and adherence. SOIE was pilot-tested in a mixed-methods randomized controlled trial. This report presents the experience of women and healthcare providers (HCPs) with SOIE.

Methods

A descriptive qualitative study using semi-structured interviews and thematic analysis was conducted with 20 women and 7 HCPs who participated in the program.

Results

Most women and HCPs reported high satisfaction with the program. Women felt it addressed their need for information and strategies to manage side effects. They felt supported and developed a more positive attitude toward AET, which contributed to their intention to pursue AET. They perceived that the program helped them navigate the AET experience and reduced their stress or fear regarding AET. HCPs corroborated these benefits.

Conclusions

Findings suggest that SOIE can enhance the experience and motivation to pursue the AET treatment by meeting important needs for information, side-effects management, and psycho-emotional support. Programs like SOIE can have benefits beyond adherence by improving patients’ well-being during this crucial long-term treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHealth PersonnelAntineoplastic Agents, HormonalMedication AdherenceHumansFemaleQualitative ResearchMiddle AgedChemotherapy, AdjuvantAdultAged

Stichwörter der Autor:innen

aromatase inhibitorsbreast neoplasmsmedication adherencepilot studyqualitative researchrandomized clinical trialsurvivorshiptamoxifen

Substanzen

Antineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Population Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, Canada.
  • Faculty of Nursing, Pavillon Ferdinand-Vandry, Université Laval, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada.
  • Centre des Maladies du Sein, CHU de Québec-Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, Canada.
  • Faculty of Pharmacy, Pavillon Ferdinand-Vandry, Université Laval, 1050 Avenue de la Médecine, Québec, QC G1V 0A6, Canada.
  • Oncology Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, Canada.
  • Université Laval Cancer Research Center, 9, McMahon Street, Québec, QC G1R 3S3, Canada.

ORCID-Profile: Line Guénette

Förderung

  • Canadian Institutes of Health Research (CIHR)
  • Fondation du CHU de Québec-Université Laval
  • Unité Soutien SSA du Québec
  • Fonds de recherche du Québec—Santé (Québec Health Research Fund)
  • Bourse de formation Desjardins pour la recherche et l’innovation de la Fondation du CHU de Québec-Université Laval

Zitieren

APA

Turcotte, V., Guillaumie, L., Lemay, M., Dionne, A., Lemieux, J., Labbé, A., Gotay, C., Guénette, L., & Lauzier, S. (2025). Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study. Current Oncology. https://doi.org/10.3390/curroncol32010045

Vancouver

Turcotte V, Guillaumie L, Lemay M, Dionne A, Lemieux J, Labbé A, et al. Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study. Current Oncology. 2025. doi:10.3390/curroncol32010045

BibTeX
@article{Turcotte2025,
  author = {Turcotte, Véronique and Guillaumie, Laurence and Lemay, Martine and Dionne, Anne and Lemieux, Julie and Labbé, Angéline and Gotay, Carolyn and Guénette, Line and Lauzier, Sophie},
  title = {Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32010045}
}
Kostenlos starten →